GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 08, 2025 |
PDB ID | UniProt ID | Title | Descriptor |
---|---|---|---|
8D8R | 8D8R | SARS-CoV-2 Spike RBD in complex with DMAb 2196 | |
8GVM | P00396 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P68530 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00415 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00423 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00426 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00428 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P07471 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00429 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P04038 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P07470 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P13183 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00430 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P10175 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8H10 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-2 Conformation | |
8H13 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Closed Conformation | |
8H14 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x3 Disulfide (D414C and V969C), Locked-1 Conformation | |
7WTF | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab XGv051 | |
7WTF | 7WTF | SARS-CoV-2 Omicron variant spike in complex with Fab XGv051 | |
7WTK | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab XGv286 | |
7WTK | 7WTK | SARS-CoV-2 Omicron variant spike in complex with Fab XGv286 | |
7X2M | 7X2M | Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD | |
7X2M | P0DTC2 | Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD | |
7ZHV | A2CIL3 | Leishmania donovani Glucose 6-Phosphate Dehydrogenase complexed with Glucose 6-Phosphate | |
7ZHW | A2CIL3 | Leishmania donovani Glucose 6-Phosphate Dehydrogenase complexed with NADP(H) and Glucose 6-Phosphate | |
7ZHZ | A2CIL3 | Leishmania donovani Glucose 6-Phosphate Dehydrogenase mutant C138S complexed with G6P and NADP(H) | |
8BSP | Q6P988 | Notum Inhibitor ARUK3006560 | |
8BSQ | Q6P988 | Notum Inhibitor ARUK3006561 | |
8BSR | Q6P988 | Notum Inhibitor ARUK3006562 | |
8BSZ | Q6P988 | Notum Inhibitor ARUK3005522 | |
8BT0 | Q6P988 | Notum Inhibitor ARUK3005518 | |
8BT2 | Q6P988 | Notum Inhibitor ARUK3004876 | |
8BT5 | Q6P988 | Notum Inhibitor ARUK3004877 | |
8BT7 | Q6P988 | Notum Inhibitor ARUK3004903 | |
8BTA | Q6P988 | Notum Inhibitor ARUK3004308 | |
8BTC | Q6P988 | Notum Inhibitor ARUK3004558 | |
8BTE | Q6P988 | Notum Inhibitor ARUK3004470 | |
8BTH | Q6P988 | Notum Inhibitor ARUK3004552 | |
8BTI | Q6P988 | Notum Inhibitor ARUK3004556 | |
8DC5 | A0A7T6Y557 | CCHFV GP38 Hoti/Kosovo | |
8DDK | 8DDK | CCHFV GP38 Hoti/Kosovo bound with CC5_17 | |
8DDK | A0A7T6Y557 | CCHFV GP38 Hoti/Kosovo bound with CC5_17 | |
8DIU | 8DIU | Cryo-EM structure of influenza A virus A/Bayern/7/1995 hemagglutinin bound to CR6261 Fab | |
8EPL | Q15878 | Human R-type voltage-gated calcium channel Cav2.3 at 3.1 Angstrom resolution | |
8EPL | P54284 | Human R-type voltage-gated calcium channel Cav2.3 at 3.1 Angstrom resolution | |
8EPL | P54289 | Human R-type voltage-gated calcium channel Cav2.3 at 3.1 Angstrom resolution | |
8EPM | Q15878 | Human R-type voltage-gated calcium channel Cav2.3 CH2II-deleted mutant at 3.1 Angstrom resolution | |
8EPM | P54289 | Human R-type voltage-gated calcium channel Cav2.3 CH2II-deleted mutant at 3.1 Angstrom resolution | |
7QFY | M1UZ70 | Fusarium oxysporum M36 protease without the propeptide | |
7QHD | P06276 | Human Butyrylcholinesterase in complex with (S)-1-(4-((2-(1H-indol-3-yl)ethyl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024